Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000866652 | SCV001007778 | likely benign | Retinoblastoma | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001013428 | SCV001174011 | likely benign | Hereditary cancer-predisposing syndrome | 2019-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001013428 | SCV002530807 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-25 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000866652 | SCV004844705 | likely benign | Retinoblastoma | 2023-12-13 | criteria provided, single submitter | clinical testing |